Christine L. Cole

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

Alasdair Munro, Shuo Feng, Leila Janani et al. · The Lancet Infectious Diseases · 2022 · 170 citations · Full text

Use of a Peer Support Intervention for Promoting Academic Engagement of Students with Autism in General Education Settings

Erin E. McCurdy, Christine L. Cole · Journal of Autism and Developmental Disorders · 2013 · 95 citations

Academic Engagement, Peer Support Intervention, Behavioral Sciences +9

Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial

Saye Khoo, Richard J. Fitzgerald, Geoffrey Saunders et al. · The Lancet Infectious Diseases · 2022 · 76 citations · Full text

Vaccination, Covid-19 Pandemic, Vaccine Trial +8

Effects of Within-Activity Choices on the Challenging Behavior of Children with Severe Developmental Disabilities

Christine L. Cole, Tara R. Levinson · Journal of Positive Behavior Interventions · 2002 · 62 citations

Instructional Routines, Disability, Education +22

EFFECTS OF A DIRECT INSTRUCTION MAIN IDEA SUMMARIZATION PROGRAM AND SELF‐MONITORING ON READING COMPREHENSION OF MIDDLE SCHOOL STUDENTS WITH LEARNING DISABILITIES

Asha K. Jitendra, Christine L. Cole, Mary Kay Hoppes et al. · Reading & Writing Quarterly · 1998 · 56 citations

Disability, Language Development, Education +17